GF
MRTX

Gabelli Funds’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Gabelli Funds’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-241,587
Closed -$14.2M – 1155
2023
Q4 		$14.2M Buy
+241,587
New +$13.6M 0.11% 242

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's MRTX Position: Q1 2024 in Review

Gabelli Funds sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 241,587 shares — an estimated $14.2M sold.

Gabelli Funds first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $14.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Gabelli Funds reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Gabelli Funds sold 241,587 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $14.2M.
  • Gabelli Funds first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Gabelli Funds's Mirati Therapeutics, Inc. Common Stock position peaked at $14.2M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Gabelli Funds's 13F filing for Q1 2024, filed 14 May 2024.